Patricia Dickson

5.0k total citations
109 papers, 1.9k citations indexed

About

Patricia Dickson is a scholar working on Physiology, Rheumatology and Organic Chemistry. According to data from OpenAlex, Patricia Dickson has authored 109 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Physiology, 36 papers in Rheumatology and 15 papers in Organic Chemistry. Recurrent topics in Patricia Dickson's work include Lysosomal Storage Disorders Research (74 papers), Glycogen Storage Diseases and Myoclonus (31 papers) and Carbohydrate Chemistry and Synthesis (15 papers). Patricia Dickson is often cited by papers focused on Lysosomal Storage Disorders Research (74 papers), Glycogen Storage Diseases and Myoclonus (31 papers) and Carbohydrate Chemistry and Synthesis (15 papers). Patricia Dickson collaborates with scholars based in United States, United Kingdom and Italy. Patricia Dickson's co-authors include Merry Passage, Steven Q. Le, Emil Kakkis, Michael F. McEntee, Carole Vogler, Stephen R. Hanson, Maurizio Scarpa, Agnes H. Chen, Beth Levy and David J. Begley and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Patricia Dickson

99 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patricia Dickson United States 23 1.1k 426 415 374 321 109 1.9k
Francyne Kubaski United States 24 1.2k 1.0× 522 1.2× 346 0.8× 268 0.7× 297 0.9× 79 1.5k
Agata Fiumara Italy 27 1.0k 0.9× 352 0.8× 1.1k 2.5× 350 0.9× 285 0.9× 131 2.4k
Irène Maire France 21 950 0.8× 387 0.9× 351 0.8× 379 1.0× 358 1.1× 42 1.5k
Roseline Froissart France 27 2.1k 1.8× 781 1.8× 804 1.9× 646 1.7× 657 2.0× 90 2.8k
Marianne Rohrbach Switzerland 26 897 0.8× 381 0.9× 631 1.5× 638 1.7× 253 0.8× 81 2.4k
Nicole Muschol Germany 23 893 0.8× 297 0.7× 291 0.7× 228 0.6× 253 0.8× 93 1.3k
Charles Marques Lourenço Brazil 23 667 0.6× 187 0.4× 883 2.1× 144 0.4× 247 0.8× 106 1.9k
Gheona Altarescu Israel 29 2.1k 1.8× 750 1.8× 795 1.9× 555 1.5× 848 2.6× 126 3.4k
G. T. N. Besley United Kingdom 26 904 0.8× 196 0.5× 948 2.3× 254 0.7× 210 0.7× 87 1.9k
C B Whitley United States 17 556 0.5× 214 0.5× 287 0.7× 209 0.6× 143 0.4× 30 970

Countries citing papers authored by Patricia Dickson

Since Specialization
Citations

This map shows the geographic impact of Patricia Dickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Dickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Dickson more than expected).

Fields of papers citing papers by Patricia Dickson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Dickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Dickson. The network helps show where Patricia Dickson may publish in the future.

Co-authorship network of co-authors of Patricia Dickson

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Dickson. A scholar is included among the top collaborators of Patricia Dickson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Dickson. Patricia Dickson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dickson, Patricia, et al.. (2025). Neuronal ceroid lipofuscinosis: underlying mechanisms and emerging therapeutic targets. Nature Reviews Neurology. 21(11). 606–622. 1 indexed citations
2.
Rensing, Nicholas, Hemanth R. Nelvagal, Steven Q. Le, et al.. (2025). GABAergic interneurons contribute to the fatal seizure phenotype of CLN2 disease mice. JCI Insight. 10(19). 1 indexed citations
3.
Muenzer, Joseph, Carole Ho, Heather Lau, et al.. (2024). Community consensus for Heparan sulfate as a biomarker to support accelerated approval in Neuronopathic Mucopolysaccharidoses. Molecular Genetics and Metabolism. 142(4). 108535–108535. 5 indexed citations
4.
He, Miao, Parith Wongkittichote, Silvia Radenkovic, et al.. (2024). D-mannose as a new therapy for fucokinase deficiency-related congenital disorder of glycosylation (FCSK-CDG). Molecular Genetics and Metabolism. 142(2). 108488–108488. 4 indexed citations
5.
Wang, Raymond, Shih‐hsin Kan, Haoyue Zhang, et al.. (2023). Intra-Articular AAV9 α-l-Iduronidase Gene Replacement in the Canine Model of Mucopolysaccharidosis Type I. PubMed. 2023(1). 1–14.
6.
Kan, Shih‐hsin, Steven Q. Le, Jonathan D. Cooper, et al.. (2021). Biochemical evaluation of intracerebroventricular rhNAGLU-IGF2 enzyme replacement therapy in neonatal mice with Sanfilippo B syndrome. Molecular Genetics and Metabolism. 133(2). 185–192. 2 indexed citations
7.
Wongkittichote, Parith, et al.. (2020). Fatal COVID‐19 infection in a patient with long‐chain 3‐hydroxyacyl‐CoA dehydrogenase deficiency: A case report. JIMD Reports. 56(1). 40–45. 11 indexed citations
8.
9.
Le, Steven Q., Merry Passage, Jillian R. Brown, et al.. (2019). Evaluation of non-reducing end pathologic glycosaminoglycan detection method for monitoring therapeutic response to enzyme replacement therapy in human mucopolysaccharidosis I. Molecular Genetics and Metabolism. 129(2). 91–97. 6 indexed citations
10.
Labounek, René, et al.. (2019). In-vivo cortical thickness estimation from high-resolution T1w MRI scans in healthy and mucopolysaccharidosis affected dogs. PubMed. 2019. 2848–2851. 2 indexed citations
11.
Stocker, Thomas J., Simon Deseive, Marcus Y. Chen, et al.. (2017). Rationale and design of the worldwide prospective multicenter registry on radiation dose estimates of cardiac CT angiography in daily practice in 2017 (PROTECTION VI). Journal of cardiovascular computed tomography. 12(1). 81–85. 7 indexed citations
12.
Polgreen, Lynda E., Alicia Kunin‐Batson, Kyle Rudser, et al.. (2017). Pilot study of the safety and effect of adalimumab on pain, physical function, and musculoskeletal disease in mucopolysaccharidosis types I and II. Molecular Genetics and Metabolism Reports. 10. 75–80. 20 indexed citations
13.
Raymond, Gerald V., Marzia Pasquali, Lynda E. Polgreen, et al.. (2016). Elevated cerebral spinal fluid biomarkers in children with mucopolysaccharidosis I-H. Scientific Reports. 6(1). 38305–38305. 22 indexed citations
14.
Shah, Anuja, Cynthia C. Nast, Mark D. Adams, et al.. (2014). Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing. eScholarship (California Digital Library). 1 indexed citations
15.
Wang, Raymond, Michael F. McEntee, Shih‐hsin Kan, et al.. (2014). Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I. Molecular Genetics and Metabolism. 112(4). 286–293. 14 indexed citations
16.
Chen, Agnes, Carole Vogler, Michael F. McEntee, et al.. (2011). Glycosaminoglycan storage in neuroanatomical regions of mucopolysaccharidosis I dogs following intrathecal recombinant human iduronidase. Apmis. 119(8). 513–521. 13 indexed citations
17.
Dickson, Patricia, Jonathan S. Wall, Merry Passage, et al.. (2011). Arterial pathology in canine mucopolysaccharidosis-I and response to therapy. Laboratory Investigation. 91(5). 665–674. 18 indexed citations
18.
Chen, Agnes & Patricia Dickson. (2010). Intrathecal enzyme replacement therapy to treat spinal cord compression in mucopolysaccharidosis: Overview and rationale. Journal of Pediatric Rehabilitation Medicine. 3(1). 7–11. 3 indexed citations
19.
Kakkis, Emil, Michael F. McEntee, Carole Vogler, et al.. (2004). Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I. Molecular Genetics and Metabolism. 83(1-2). 163–174. 133 indexed citations
20.
Dickson, Patricia, et al.. (2004). Normal right and left ventricular mass development during early infancy. The American Journal of Cardiology. 93(6). 797–801. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francyne Kubaski Breakdown of academic impact, for papers by Agata Fiumara Breakdown of academic impact, for papers by Irène Maire Breakdown of academic impact, for papers by Roseline Froissart Breakdown of academic impact, for papers by Marianne Rohrbach Breakdown of academic impact, for papers by Nicole Muschol Breakdown of academic impact, for papers by Charles Marques Lourenço Breakdown of academic impact, for papers by Gheona Altarescu Breakdown of academic impact, for papers by G. T. N. Besley Breakdown of academic impact, for papers by C B Whitley
Rankless by CCL
2026